BIOS Fund II, LP insider trades

BIOS Fund II, LP has filed 5 Form 4s with the SEC that we hold, for Actuate Therapeutics, INC. (ACTU) (Director, 10% owner), In8Bio, INC. (INAB) (10% owner) and Lantern Pharma Inc. (LTRN) (10% owner). Across all of them we count 4 purchases worth $3.9M and 5 sales worth $233.5K reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a purchase of 1,349,218 shares of In8Bio, INC. worth $2.6M, dated 2022-08-16. The first filing on our record is dated 2022-08-17 and the latest 2025-06-30.

Actuate Therapeutics, INC. (ACTU)

Director, 10% owner · 2 filings · 4 purchases and sales

Trade date	Code	Shares	Value as filed	Filed	Source
2024-08-14	S, sale reported on Form 4	2,324	$18.6K	2024-08-20	SEC
2024-08-14	S, sale reported on Form 4	5,314	$42.5K	2024-08-20	SEC
2024-08-14	S, sale reported on Form 4	17,361	$138.9K	2024-08-20	SEC
2025-06-27	P, purchase reported on Form 4	71,428	$500.0K	2025-06-30	SEC

In8Bio, INC. (INAB)

10% owner · 2 filings · 3 purchases and sales

Trade date	Code	Shares	Value as filed	Filed	Source
2022-08-16	P, purchase reported on Form 4	217,891	$414.0K	2022-08-17	SEC
2022-08-16	P, purchase reported on Form 4	1,349,218	$2.6M	2022-08-17	SEC
2022-08-16	P, purchase reported on Form 4	206,575	$392.5K	2022-08-17	SEC

Lantern Pharma Inc. (LTRN)

10% owner · 1 filing · 2 purchases and sales

Trade date	Code	Shares	Value as filed	Filed	Source
2022-09-02	S, sale reported on Form 4	1,275	$6.6K	2022-09-07	SEC
2022-09-02	S, sale reported on Form 4	5,170	$26.9K	2022-09-07	SEC

Source

Counted from the Form 4 filings this reporting owner (SEC CIK 1714576) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.

Source: U.S. Securities and Exchange Commission (EDGAR) and other official government data · Updated 2026-10-27 · For informational purposes only, not investment advice.
Privacy · Terms